Signal Peptide Peptidase Cleavage of GB Virus B Core Protein Is Required for Productive Infection in Vivo*

  1. Paul Targett-Adams,
  2. Torsten Schaller,
  3. Graham Hope,
  4. Robert E. Lanford§,
  5. Stanley M. Lemon,
  6. Annette Martin and
  7. John McLauchlan1
  1. Medical Research Council Virology Unit, Church Street, Glasgow, G11 5JR, United Kingdom, §Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, Texas 78227, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas 77555-1019, and UnitédeGénétique Moléculaire des Virus Respiratoires, CNRS-URA 1966, Institut Pasteur, 25 Rue du Dr. Roux, 75724 Paris Cedex 15, France
  1. 1 To whom correspondence should be addressed: MRC Virology Unit, Church St., Glasgow, G11 5JR, United Kingdom. Tel.: 44-141-330-4028; Fax: 44-141-330-3520; E-mail: j.mclauchlan{at}mrcvu.gla.ac.uk.

Abstract

Chronic infection by hepatitis C virus (HCV) is a leading cause of liver disease for which better therapies are urgently needed. Because a clearer understanding of the viral life cycle may suggest novel anti-viral approaches, we studied the role of host signal peptide peptidase (SPP) in viral infection. This intramembrane protease cleaves within a C-terminal signal sequence in the viral core protein, but the molecular determinants of cleavage and whether it is required for infection in vivo are unknown. To answer these questions, we studied SPP processing in GB virus B (GBV-B) infection. GBV-B is the closest phylogenetic relative of HCV and offers an accurate surrogate model for HCV infection. We demonstrate that SPP also processes GBV-B core protein and that a serine residue in the hydrophobic region of the signal sequence (present also in HCV) is critical for efficient SPP cleavage. The small size of the serine side chain combined with its ability to form intra- and interhelical hydrogen bonds likely contributes to recognition of the signal sequence as a substrate for SPP. By introducing mutations with differing effects on SPP processing into an infectious GBV-B molecular clone, we demonstrate that SPP processing of the core protein is required for productive infection in primates. These results broaden our understanding of the mechanism and requirements for SPP cleavage and reveal a functional role in vivo for intramembrane proteolysis in host-pathogen interactions. Moreover, they identify SPP as a potential therapeutic target for reducing the impact of HCV infection.

Footnotes

  • 2 The abbreviations used are: SPP, signal peptide peptidase; HCV, hepatitis C virus; ER, endoplasmic reticulum; GBV-B, GB virus B; WT, wild type; BHK, baby hamster kidney; ALT, alanine aminotransferase; CSFV, classical swine fever virus; ge, genome equivalent.

  • 3 P. Targett-Adams, T. Schaller, G. Hope, R. E. Lanford, S. M. Lemon, A. Martin, and J. McLauchlan, unpublished observations.

  • 4 A. Martin, P. Targett-Adams, T. Schaller, G. Hope, R. E. Lanford, S. M. Lemon, and J. McLauchlan, unpublished.

  • * This work was supported by the United Kingdom Medical Research Council (MRC) and in part by Grants RO1-AI49574, R24-RR15081, and U19-AI40035 from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Received June 5, 2006.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement